Ellen Brauers
Ellen Brauers

Ellen Brauers

Associate, Responsible Investment team

Latest articles

January 2024

ESG Viewpoint: Diversity in clinical trials  

Despite a clear scientific and commercial imperative, a significant gap between patient and trial populations persists. We explain why diversity in clinical trials matters to investors and explore our engagement with companies.
April 2023

ESG Viewpoint: Health Matters – the importance of public health for investors

Covid-19 underlined why public health matters to investors. We explore the role we play through stewardship and the allocation of capital as well as related investment opportunities. Read more in our latest ESG Viewpoint.

Latest articles

January 2024

ESG Viewpoint: Diversity in clinical trials  

Despite a clear scientific and commercial imperative, a significant gap between patient and trial populations persists. We explain why diversity in clinical trials matters to investors and explore our engagement with companies.
April 2023

ESG Viewpoint: Health Matters – the importance of public health for investors

Covid-19 underlined why public health matters to investors. We explore the role we play through stewardship and the allocation of capital as well as related investment opportunities. Read more in our latest ESG Viewpoint.
Load more articles

Thank you. You can now visit your preference centre to choose which insights you would like to receive by email.

To view and control which insights you receive from us by email, please visit your preference centre.

Play Video

CT Property Trust- Fund Manager Update

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium